Non sterile Manufacturing - Semi solids
Eurofins CDMO (Contract Development & Manufacturing Organization) provides integrated, end-to-end drug development solutions supporting clients from the earliest phases of API research and development through finished products.
We offer a full suite of drug development services encompassing preclinical development, formulation screening and development, analytical development of semi solid dosage forms for skin, mucosal or oral delivery. The developed drug products can be scaled-up for clinical trial manufacturing.
With more than two decades of development and manufacturing experience and 13 state-of-the-art facilities worldwide, Eurofins CDMO provides high-quality, customized solutions for complex products and unique production processes, specializing in the development of innovative formulation technologies and solutions to enhance bioavailability, prevent aggregation, improve stability and/or control drug release for difficult-to-formulate drug candidates and existing drugs.
Choose Eurofins CDMO to help you:
- Accelerate preclinical and clinical phases of your product with easy scale-up and smooth transfer from development to GMP facilities
- Develop and manufacture semi solid dosage forms of chemical and biologic drug candidates and existing drugs
- Find innovative solutions for difficult to formulate drugs
- Perform analytical method development/validation, release and stability evaluation (Accelerated stability, ICH stability, ASAP) for developed and manufactured drug products